Schroder Investment Management Group Dyne Therapeutics, Inc. Call Options Transaction History
Schroder Investment Management Group
- $122 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DYN
# of Institutions
220Shares Held
130MCall Options Held
36.5KPut Options Held
138K-
Janus Henderson Group PLC London, X014.7MShares$278 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.76MShares$184 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA9.71MShares$183 Million2.02% of portfolio
-
Atlas Venture Life Science Advisors, LLC9.13MShares$172 Million26.07% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$139 Million0.01% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $975M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...